These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 17136757)

  • 1. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion.
    Ong CT; Khoo YT; Tan EK; Mukhopadhyay A; Do DV; Han HC; Lim IJ; Phan TT
    J Pathol; 2007 Jan; 211(1):95-108. PubMed ID: 17136757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices.
    Mukhopadhyay A; Tan EK; Khoo YT; Chan SY; Lim IJ; Phan TT
    Br J Dermatol; 2005 Apr; 152(4):639-45. PubMed ID: 15840092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
    Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT
    J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.
    Zhang GY; Yi CG; Li X; Zheng Y; Niu ZG; Xia W; Meng Z; Meng CY; Guo SZ
    Arch Dermatol Res; 2008 Apr; 300(4):177-84. PubMed ID: 18239926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro.
    Riedel K; Riedel F; Goessler UR; Germann G; Sauerbier M
    Arch Med Res; 2007 Jan; 38(1):45-51. PubMed ID: 17174722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis.
    Khoo YT; Ong CT; Mukhopadhyay A; Han HC; Do DV; Lim IJ; Phan TT
    J Cell Physiol; 2006 Aug; 208(2):336-43. PubMed ID: 16705627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells.
    Xia W; Phan TT; Lim IJ; Longaker MT; Yang GP
    Wound Repair Regen; 2004; 12(5):546-56. PubMed ID: 15453837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
    Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
    Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis.
    Mukhopadhyay A; Wong MY; Chan SY; Do DV; Khoo A; Ong CT; Cheong HH; Lim IJ; Phan TT
    J Trauma; 2010 Apr; 68(4):999-1008. PubMed ID: 20386290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts.
    Florin L; Maas-Szabowski N; Werner S; Szabowski A; Angel P
    J Cell Sci; 2005 May; 118(Pt 9):1981-9. PubMed ID: 15840658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.
    Riedel K; Koellensperger E; Ryssel H; Riedel F; Goessler UR; Germann G; Kremer T
    Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation.
    Rossiter H; Barresi C; Pammer J; Rendl M; Haigh J; Wagner EF; Tschachler E
    Cancer Res; 2004 May; 64(10):3508-16. PubMed ID: 15150105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF is upregulated in a neuroblastoma and hepatocyte coculture model.
    Beierle EA; Strande LF; Berger AC; Chen MK
    J Surg Res; 2001 May; 97(1):34-40. PubMed ID: 11319877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple in vitro model for investigating epithelial/mesenchymal interactions: keratinocyte inhibition of fibroblast proliferation and fibronectin synthesis.
    Harrison CA; Dalley AJ; Mac Neil S
    Wound Repair Regen; 2005; 13(6):543-50. PubMed ID: 16283869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
    Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between stromal fibroblasts and colorectal cancer cells in the expression of vascular endothelial growth factor.
    Koshida Y; Kuranami M; Watanabe M
    J Surg Res; 2006 Aug; 134(2):270-7. PubMed ID: 16600304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart.
    Nakamura K; Sata M; Iwata H; Sakai Y; Hirata Y; Kugiyama K; Nagai R
    Clin Sci (Lond); 2007 Jun; 112(12):607-16. PubMed ID: 17263691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.